Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma

Current Molecular Pharmacology · Published 2025-01-01 · DOI 10.1016/j.cmp.2025.06.002

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.cmp.2025.06.002

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles